Pharmdca (@Pharmdca) header
Pharmdca (@Pharmdca) profile picture

USC Pharmacy Alumni 💊 | Full-Time Investor 📈 My posts reflect my personal investment views, not investment recommendations. Always do your own due diligence.

United States
Joined September 2013
Photo by Pharmdca (@Pharmdca)Photo by Pharmdca (@Pharmdca)Photo by Pharmdca (@Pharmdca)Photo by Pharmdca (@Pharmdca)Photo by Pharmdca (@Pharmdca)Photo by Pharmdca (@Pharmdca)Photo by Pharmdca (@Pharmdca)Photo by Pharmdca (@Pharmdca)Photo by Pharmdca (@Pharmdca)Photo by Pharmdca (@Pharmdca)
LT position PART 1 Portfolio Positions acquired: $RNA $DAWN $SLNO $NARI $BPMC $MYOV base:0x9bba915f036158582c20b51113b925f243a1a1a1 $KRTX $HZNP $PRVB $ISEE $BLU $CTIC $FSTX $ICVX $LVGO $STML base:0x4e6c9f48f73e54ee5f3ab7e2992b2d733d0d0b07 $CMRX $RLYP $ITCI $KVUE Tech positions: In order $AMZN $META $NVDA $MSFT $SOFI $GOOGL $RDDT $MELI $APP $RKLB $INTC $IREN $NBIS $CRDO $AAOI $BE $AXON $MDB Biotech positions: $VKTX $CYTK $ARDX $HROW $MDGL $CRVS $ABVX $TMDX $RVMD $NKTR $CELC $AVR
9
8
41
64,256
Pharmdca retweeted
Bernie Sanders: "Democrats are working with Trump to pass a bill that fast tracks data center construction" - $NBIS $IREN $CRWV $NVDA
Voters said NO to data centers in the election. Now some Democrats are working with Trump to pass a bill that fast tracks data center construction and gives more handouts to the fossil fuel industry. Really? NO to Big Oil. NO to data centers. NO to their permitting bill.
Readers added context they thought people might want to know
The Senate-passed BAAJA bill speeds energy project permitting, which critics say aids data centers and fossil fuels. It also requires large data centers to cover their own grid costs, protecting ratepayers. usatoday.com/story/news/pol… energy.senate.gov/press/dem/fact…
1
3
1
48
12,975
This month should be dedicated to Hackers. Airlines, Banks, National Security Network and now U.S Department of Agriculture What’s going on
8
1
18
9,658
This will pass.
15
3
75
11,074
$ZS panic selling at a loss earlier this year and now news about getting acquired by $CRWD How things change quickly.
3
1
18
8,686
Potential blockbuster M&A in cybersecurity. Bloomberg reporting that $CRWD is in talks to buy $ZS. Would give the endpoint titan (& so much more now) a lot more muscle in network. Would give CrowdStrike a far more complete product suite to match $PANW's breadth too. While Zscaler may be struggling a bit to expand to other categories... they are world-class in network. CrowdStrike is world-class in a lot of other things. Seems like a good fit.
9
3
1
129
20,839
CROWDSTRIKE $CRWD IS SAID IN TALKS TO BUY CYBERSECURITY FIRM ZSCALER $ZS
6
51
34
428
99,604
$VIX almost hit 52-week highs.
3
8
7,214
$NVDA News flow continue to pile on. True or false, every headline creates another round of debate, fear, and uncertainty. It's been quite painful for the market and investors since Jensen entered the spotlight.
6
30
10,548
Genius
TRUMP SAYS HE EXPECTED OIL TO REACH $300 A BARREL, NOW NEAR $80
1
12
9,566
You weren't Warren Buffett 2.0 on the way up. You are not an idiot today. We are both somewhere firmly in between. And as long as we're acting responsibly, that's entirely fine. We will be fine. There will be brighter days. Great companies will not get cheaper forever.
9
4
1
189
16,097
$VIX 52-week highs of $35.3. Will it breach through the highs before a pullback?
1
16
7,563
$ABVX In a nutshell from my investing experience in Biotech sector. It takes years of execution, clinical success, and capital allocation to build value in a company and garner investor confidence. Yet it can take just one short report to inject uncertainty and erase months of progress in the eyes of the market. Destroying sentiment can take a single short report.
14
7,434
$SPY just shy away from $700 print. What a month it has been so far.
12
6,934
$ABVX The market valuation has been cut nearly in half from its highs. At current levels, the company could become a much more attractive acquisition target for BP.
1
1
15
7,351
$ABVX Scorpion Short report- Another one taking advantage of current market conditions.
1
1
31
9,348
$ABVX What happened- Down 20%
4
9
11,597
$RVMD clearing event. Stock down on anticipation of $ERAS data this morning. Pullback is a good opportunity to add $RVMD demonstrating a clear transitioning into commercial stage post drug launch with revenue of $198 million in just 5 weeks (partial quarter). Company is moving into transformational period with no competition for next few years and to expand into earlier clinical settings and validation across other cancers like NSCLC etc.
1
11
7,073
I rather buy $SPCX than $ANT
5
59
9,313
SANDISK $SNDK 8-FOR-1 STOCK SPLIT IS NOW EFFECTIVE
27
51
16
1,028
147,111
TRUMP WILL DELIVER A KEYNOTE ADDRESS ON THE IRAN WAR NEXT MONTH: THE NEW YORK POST
25
12
10
219
57,965